We report on gene therapy for Wiskott-Aldrich syndrome, a breakthrough treatment showing promising results in clinical trials (NCT03537496), with 90% efficacy rates, now available at top US hospitals.
The Gene Editing Revolution That’s Curing Diseases by Rewriting DNA
We analyze the current state of CRISPR gene editing technology and its applications in curing diseases by rewriting DNA.
Clotting Revolution: Long-Term Gene Therapy Solutions for Hemophilia
Discover groundbreaking gene therapy solutions for hemophilia. Learn how this revolutionary treatment offers long-term clotting factor production, reducing bleeding risks and improving quality of life.